AI Research
Chai Discovery Raises $400M at a $3.8B Valuation to Scale AI Molecular Design
The drug-discovery lab's Series C, led by Index Ventures, roughly triples its valuation in seven months as its models push AI-designed antibodies toward Pfizer, Eli Lilly and Novartis.
1d ago
